A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and business, public, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 160 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 75 countries worldwide.

The Roscongress Foundation has Telegram channels in Russian (t.me/Roscongress), English (t.me/RoscongressDirect), and Spanish (t.me/RoscongressEsp). Official website and Information and Analytical System of the Roscongress Foundation: roscongress.org.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Priority Strategies in the Supply of Drugs
8 June 2019
08:30—10:00

Improvements in the availability of drugs require implementation of such key elements of the system as smart selection, affordable prices, adequate quantitative assessment, and forecasting, timely procurement as well as proper storage and distribution. Over the past years Russia has significantly reduced the time it takes to introduce drugs into the market, while maintaining the quality standards, and taken measures to prevent the circulation of counterfeit products, as well as expanded the list of vital and essential drugs. Notwithstanding factors such as emergence of more expensive high-quality drugs, the expansion of the list of such drugs, and the support provided to domestic innovations, insufficient efforts have been made to improve the distribution and procurement operations and track the true efficiency of the drugs. Two key priorities for the strategy have been identified: introduction of insurance covering drugs and an increase in the state funding of drugs. The effective use of the funds largely determines the success of the National Drug Policy, and the quality of state regulation could be a major benchmark compared with the increase in costs. Should the growth in public investment be linked to greater state regulation requirements? How can the access to medicines be ensured? What difficulties do manufacturers, distributors, and doctors encounter when working within the government procurement frameworks and how can they be overcome? How much funding will be required to achieve significant results? How should targets be set in the National Drug Policy? What is the demand in the Russian domestic market for innovative drugs?

Date
08.06.2019
Forum
SPIEF
Started at
08:30—10:00
Conference hall
Congress Centre, Business Breakfast hall 2
Analytics on the topic